Daratumumab induced Minimal Residual Disease Negative Remission in CD 38 (dim) Positive Pediatric Acute Myeloid Leukemia
Pronamee Borah1, Dinah Ng1, Nitin Dayal2, Sangeeta Pathak3, Rahul Naithani1
1Hematology and Bone Marrow Transplant Division, Max Superspecialty Hospital, Delhi, India
2Department of Lab Medicine, Max Superspecialty Hospital, Delhi, India
3Department of Transfusion medicine, Max Superspecialty Hospital, Delhi, India
Conflicts of interest: None to declare.
No financial support was obtained in this study.
Text word count 815
Brief running title: Daratumumab in Pediatric AML
Key Words: Daratumumab, AML, Children
Tables: 0; Figures: 0